Tanvex BioPharma Financials
| 6541 Stock | TWD 70.30 2.20 3.23% |
Tanvex |
Understanding current and past Tanvex BioPharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tanvex BioPharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Tanvex BioPharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Tanvex BioPharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tanvex BioPharma. Check Tanvex BioPharma's Beneish M Score to see the likelihood of Tanvex BioPharma's management manipulating its earnings.
Tanvex BioPharma Stock Summary
Tanvex BioPharma competes with OBI Pharma, Adimmune Corp. Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. TANVEX BIOPHARMA is traded on Taiwan Stock Exchange in Taiwan.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | KYG8676P1037 |
| Business Address | 802 West Bay |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.tanvex.com |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Tanvex BioPharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Tanvex Stock, because this is throwing your money away. Analyzing the key information contained in Tanvex BioPharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Tanvex BioPharma Key Financial Ratios
There are many critical financial ratios that Tanvex BioPharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Tanvex BioPharma reports annually and quarterly.Tanvex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tanvex BioPharma's current stock value. Our valuation model uses many indicators to compare Tanvex BioPharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tanvex BioPharma competition to find correlations between indicators driving Tanvex BioPharma's intrinsic value. More Info.Tanvex BioPharma is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tanvex BioPharma's earnings, one of the primary drivers of an investment's value.Tanvex BioPharma Systematic Risk
Tanvex BioPharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tanvex BioPharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Tanvex BioPharma correlated with the market. If Beta is less than 0 Tanvex BioPharma generally moves in the opposite direction as compared to the market. If Tanvex BioPharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tanvex BioPharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tanvex BioPharma is generally in the same direction as the market. If Beta > 1 Tanvex BioPharma moves generally in the same direction as, but more than the movement of the benchmark.
Tanvex BioPharma November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tanvex BioPharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tanvex BioPharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tanvex BioPharma based on widely used predictive technical indicators. In general, we focus on analyzing Tanvex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tanvex BioPharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.93 | |||
| Information Ratio | 0.0697 | |||
| Maximum Drawdown | 15.1 | |||
| Value At Risk | (3.04) | |||
| Potential Upside | 6.22 |
Additional Tools for Tanvex Stock Analysis
When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.